ArticlePCN reports : psychiatry and clinical neurosciences2025
Prefronto-thalamic hypoconnectivity in schizophrenia: Monkey to human translation of critical pathways for symptom-related functions.
Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Editorial: From causal circuit mapping to clinical translation: Prefronto-thalamic hypoconnectivity in schizophrenia.PCN reports : psychiatry and clinical neurosciences · 2026Article
- Prefronto-thalamic hypoconnectivity in schizophrenia: Monkey to human translation of critical pathways for symptom-related functions.PCN reports : psychiatry and clinical neurosciences · 2025Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Recent advances in genetic neuromodulation technology have enabled circuit-specific interventions in nonhuman primates (NHPs), thereby revealing the causal functions of specific neural circuits. Using this technology, we recently identified in NHPs the causal roles of the dorsolateral prefrontal cortex (DLPFC) to the lateral part of the mediodorsal thalamic nucleus (MDl) pathway in working memory, a core deficit in schizophrenia (SCZ) patients. Here, we aimed to examine if this alteration was translational to the human patients with SCZ. Methods: Using the publicly available, multisite, multi-disorder magnetic resonance imaging (MRI) dataset, we evaluated the resting-state functional connectivity in this DLPFC-MDl pathway and examined whether the alteration was, if any, specific to SCZ ( Results: We found that the DLPFC-MDl connectivity was significantly reduced in the SCZ group compared to HCs, whereas no such hypoconnectivity was observed in the ASD or MDD groups, suggesting a disease-dependent profile of altered connectivity at rest. This hypoconnectivity was not observed between the DLPFC and other neighboring thalamic nuclei, suggesting a focal thalamic anomaly underlying the altered connectivity in SCZ. Conclusion: These results support the potential of translating pathway-specific causal insights from NHP studies to identify disease-specific connectivity alterations in neuropsychiatric disorders with related symptoms in humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.